Akamara Biomedicine Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Akamara Biomedicine
Akamara Biomedicine Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 August 2017 (Seven years and five months 3 days old ). Its registered office is in East Delhi, Delhi, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Raghunath Mashelkar, Shrikant Mantri, Shiladitya Sengupta, and One other member serve as directors at the Company.
Company Details
-
Location
East Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100DL2017PTC322917
-
Company No.
322917
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Aug 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Akamara Biomedicine?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghunath Mashelkar
|
Director | 30-Aug-2017 | Current |
|
Shrikant Mantri
|
Director | 19-Jul-2021 | Current |
|
Shiladitya Sengupta
|
Director | 30-Aug-2017 | Current |
|
Rajeev Mantri
|
Director | 19-Jul-2021 | Current |
Financial Performance of Akamara Biomedicine.
Akamara Biomedicine Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akamara Biomedicine?
Unlock access to Akamara Biomedicine's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Vyome Therapeutics LimitedRaghunath Mashelkar and Shiladitya Sengupta are mutual person
-
Vyome Biosciences Private LimitedShiladitya Sengupta and Rajeev Mantri are mutual person
-
International Longevity Centre- IndiaRaghunath Mashelkar is a mutual person
-
Gpsk Commodities Private LimitedShrikant Mantri and Rajeev Mantri are mutual person
-
Gpsk Capital Private Limited
Shrikant Mantri and Rajeev Mantri are mutual person
-
Sakal Media Private LimitedRaghunath Mashelkar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Akamara Biomedicine?
Akamara Biomedicine has a workforce of 37 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akamara Biomedicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akamara Biomedicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
